All Stories

  1. Expression and characterization of a codon-optimized blood coagulation factor VIII

    Article • Journal of Thrombosis and Haemostasis, February 2017, Wiley

    Dr Mikhail V Ovanesov, Jian-Jiang Hao

  2. Can the diagnostic reliability of the thrombin generation test as a global haemostasis assay be improved? The impact of calcium chloride concentration

    Article • Haemophilia, February 2017, Wiley

    Dr Mikhail V Ovanesov

  3. Association of immune globulin intravenous and thromboembolic adverse events

    Article • American Journal of Hematology, February 2017, Wiley

    Dr Mikhail V Ovanesov

  4. Optimization of the thrombin generation test components to measure potency of factor VIII concentrates

    Article • Haemophilia, April 2016, Wiley

    Dr Mikhail V Ovanesov

  5. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: comment

    Article • Journal of Thrombosis and Haemostasis, July 2015, Wiley

    Dr Mikhail V Ovanesov

  6. Cluster III of Low-Density Lipoprotein Receptor-Related Protein 1 Binds Activated Blood Coagulation Factor VIII

    Article • Biochemistry, January 2015, American Chemical Society (ACS)

    Dr Mikhail V Ovanesov

  7. Predicting dosing advantages of factor VIIa variants with altered tissue factor‐dependent and lipid‐dependent activities

    Article • Journal of Thrombosis and Haemostasis, August 2014, Elsevier

    Dr Mikhail V Ovanesov

  8. Immune globulins and same-day thrombotic events as recorded in a large health care database during 2008 to 2012

    Article • Transfusion, May 2014, Wiley

    Dr Mikhail V Ovanesov

  9. Hyperimmune globulins and same-day thrombotic adverse events as recorded in a large healthcare database during 2008-2011

    Article • American Journal of Hematology, September 2013, Wiley

    Dr Mikhail V Ovanesov

  10. Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma

    Article • Thrombosis Research, September 2013, Elsevier

    Dr Mikhail V Ovanesov

  11. Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII

    Article • Protein Expression and Purification, April 2013, Elsevier

    Dr Mikhail V Ovanesov

  12. Correction of microplate location effects improves performance of the thrombin generation test

    Article • Thrombosis Journal, January 2013, Springer Science + Business Media

    Dr Mikhail V Ovanesov

  13. Thrombin Activity Propagates in Space During Blood Coagulation as an Excitation Wave

    Article • Biophysical Journal, November 2012, Elsevier

    Dr Mikhail V Ovanesov

  14. Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids

    Article • Blood, May 2012, American Society of Hematology

    Dr Mikhail V Ovanesov

  15. Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010

    Article • Transfusion, March 2012, Wiley

    Dr Mikhail V Ovanesov

  16. Task-Oriented Modular Decomposition of Biological Networks: Trigger Mechanism in Blood Coagulation

    Article • Biophysical Journal, May 2010, Elsevier

    Dr Mikhail V Ovanesov

  17. Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution

    Article • Blood Coagulation & Fibrinolysis, December 2008, Wolters Kluwer Health

    Dr Mikhail V Ovanesov

  18. 327 Immunotherapy with CpG oligonucleotides and antibodies to TNFα rescue neonatal mice from lethal arena Virus-induced meningoencephalitis

    Article • Cytokine, September 2008, Elsevier

    Dr Mikhail V Ovanesov

  19. Immunotherapy with CpG Oligonucleotides and Antibodies to TNF-  Rescues Neonatal Mice from Lethal Arenavirus-Induced Meningoencephalitis

    Article • The Journal of Immunology, June 2008, The American Association of Immunologists

    Dr Mikhail V Ovanesov

  20. Enlargement of the lateral ventricles in mutant DISC1 transgenic mice

    Article • Molecular Psychiatry, January 2008, Springer Science + Business Media

    Dr Mikhail V Ovanesov

  21. Genetic contributions to influenza virus attenuation in the rat brain

    Article • Journal of NeuroVirology, January 2008, Springer Science + Business Media

    Dr Mikhail V Ovanesov

  22. Astrocytes play a key role in activation of microglia by persistent Borna disease virus infection

    Article • Journal of Neuroinflammation, January 2008, Springer Science + Business Media

    Dr Mikhail V Ovanesov

  23. Persistent Borna Disease Virus (BDV) infection activates microglia prior to a detectable loss of granule cells in the hippocampus

    Article • Journal of Neuroinflammation, January 2008, Springer Science + Business Media

    Dr Mikhail V Ovanesov

  24. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia

    Article • Molecular Psychiatry, September 2007, Springer Science + Business Media

    Dr Mikhail V Ovanesov

  25. PC12 cell model of inducible expression of mutant DISC1: New evidence for a dominant-negative mechanism of abnormal neuronal differentiation

    Article • Neuroscience Research, July 2007, Elsevier

    Dr Mikhail V Ovanesov

  26. Neonatal Borna disease virus infection in rats is associated with increased extracellular levels of glutamate and neurodegeneration in the striatum

    Article • Journal of NeuroVirology, January 2007, Springer Science + Business Media

    Dr Mikhail V Ovanesov

  27. Activation of Microglia by Borna Disease Virus Infection: In Vitro Study

    Article • Journal of Virology, October 2006, ASM Journals

    Dr Mikhail V Ovanesov

  28. Spatial Propagation and Localization of Blood Coagulation Are Regulated by Intrinsic and Protein C Pathways, Respectively

    Article • Biophysical Journal, March 2006, Elsevier

    Dr Mikhail V Ovanesov

  29. Mo-W10:5 Mechanisms of spatial clot growth on oxidized low density lipoprotein (OXLDL)-treated vascular cells as a model of atherothrombosis

    Article • Atherosclerosis Supplements, January 2006, Elsevier

    Dr Mikhail V Ovanesov

  30. Spatial Dynamics of Contact-Activated Fibrin Clot Formationin vitroandin silicoin Haemophilia B: Effects of Severity and Ahemphil B Treatment

    Article • Mathematical Modelling of Natural Phenomena, January 2006, EDP Sciences

    Dr Mikhail V Ovanesov

  31. Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate*

    Article • Journal of Thrombosis and Haemostasis, February 2005, Wiley

    Dr Mikhail V Ovanesov

  32. Inhibitors in hemophilia A

    Article • Blood Coagulation & Fibrinolysis, March 2004, Wolters Kluwer Health

    Dr Mikhail V Ovanesov

  33. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, August 2002, Elsevier

    Dr Mikhail V Ovanesov